StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > ARISTOTLE....

<< Previous

Bullboard Posts

Next >>

Comment by Str8Shuteron Mar 05, 2021 2:06am

164 Views

Post# 32725508

RE:ARISTOTLE....

Well, we all know that good news is almost never announced on a Friday or on a weekend. So, the launch day will almost certainly be on Monday. Unless it's Tuesday. Of course, Wednesday is also a strong possibility, but Thursday is about 25% likely.

I'm pretty darn sure about all of this, so now that you have a definitive answer to the same thoughtful question that you asked only 2 days ago, you can go ahead and invest accordingly.

BTW, just don't ask which week. Good luck!